Clinical trials are complex. That’s expected, given accelerated advancements in science and technology. But when that complexity creates friction in […]
A strong clinical trial protocol does more than describe how a study will run. It also helps reviewers understand why
Over the last 15 to 20 years, monoclonal antibody-based treatments, such as those targeting vascular endothelial growth factor (anti-VEGF), have
Introducing the “‘Sponsor’s Guide to IRB Approval’“ Institutional review board (IRB) approval protects the rights, safety, and welfare of research participants, and
For Jani Viox, clinical research is more than a profession—it’s personal. As a senior coordinator of client services at Advarra, Jani
Clinical trial study design forms the foundation of trial success. The decisions teams make at the design stage shape how
Fueled by automation to remove one of the biggest barriers to adoption Increasingly, research sites are not just asking how
AI is becoming a routine part of how research proposals are prepared and reviewed, from drafting applications to supporting administrative
Traditional clinical trial designs often delay progress due to rigid protocols and frequent amendments. Adaptive and platform trial models introduce flexibility and shared infrastructure, reducing startup delays, cutting costs, and enabling sponsors to conduct faster, more efficient research.
Traditional clinical trial designs often delay progress due to rigid protocols and frequent amendments. Adaptive and platform trial models introduce flexibility and shared infrastructure, reducing startup delays, cutting costs, and enabling sponsors to conduct faster, more efficient research.
For nearly a decade, Francine Lopez has helped clinical research move from idea to impact. From her early days at
Oncology research continues to push scientific boundaries, from biomarker-driven therapies to increasingly personalized treatment strategies. Operationally, however, many oncology trials
